61 related articles for article (PubMed ID: 34375498)
1. The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasia.
Morote J; Schwartzmann I; Celma A; Roche S; de Torres IM; Mast R; Semidey ME; Regis L; Santamaria A; Planas J; Trilla E
BJU Int; 2022 May; 129(5):627-633. PubMed ID: 34375498
[TBL] [Abstract][Full Text] [Related]
2. MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.
Huang C; Song G; Wang H; Ji G; Li J; Chen Y; Fan Y; Fang D; Xiong G; Xin Z; Zhou L
Biomed Res Int; 2018; 2018():6368309. PubMed ID: 30276213
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy.
Busetto GM; Del Giudice F; Maggi M; De Marco F; Porreca A; Sperduti I; Magliocca FM; Salciccia S; Chung BI; De Berardinis E; Sciarra A
World J Urol; 2021 Jun; 39(6):1869-1877. PubMed ID: 32681273
[TBL] [Abstract][Full Text] [Related]
4. The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions.
Zattoni F; Pereira LJP; Marra G; Valerio M; Olivier J; Puche-Sanz I; Rajwa P; Maggi M; Campi R; Amparore D; De Cillis S; Junlong Z; Guo H; La Bombarda G; Fuschi A; Veccia A; Ditonno F; Marquis A; Barletta F; Leni R; Serni S; Kasivisvanathan V; Antonelli A; Dal Moro F; Rivas JG; van den Bergh RCN; Briganti A; Gandaglia G; Novara G
World J Urol; 2023 Nov; 41(11):3357-3366. PubMed ID: 37755520
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging in Prostate Cancer Screening: A Systematic Review and Meta-Analysis.
Fazekas T; Shim SR; Basile G; Baboudjian M; Kói T; Przydacz M; Abufaraj M; Ploussard G; Kasivisvanathan V; Rivas JG; Gandaglia G; Szarvas T; Schoots IG; van den Bergh RCN; Leapman MS; Nyirády P; Shariat SF; Rajwa P
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38576242
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of prostate cancer with MRI and prostate-specific antigen density-based tool for personalized decision making.
Rajendran I; Lee KL; Thavaraja L; Barrett T
Br J Radiol; 2024 Jan; 97(1153):113-119. PubMed ID: 38263825
[TBL] [Abstract][Full Text] [Related]
7. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy.
Truong M; Frye TP
Transl Androl Urol; 2017 Jun; 6(3):424-431. PubMed ID: 28725584
[TBL] [Abstract][Full Text] [Related]
9. A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI.
Kaneko M; Fujihara A; Iwata T; Ramacciotti LS; Palmer SL; Oishi M; Aron M; Cacciamani GE; Duddalwar V; Horiguchi G; Teramukai S; Ukimura O; Gill IS; Abreu AL
Int Braz J Urol; 2024; 50(3):319-334. PubMed ID: 37450770
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens from non-transition and transition zones.
Takayama H; Shin M; Nonomura N; Okuyama A; Aozasa K
Jpn J Cancer Res; 2000 Sep; 91(9):941-7. PubMed ID: 11011123
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies.
Beatrici E; Frego N; Chiarelli G; Sordelli F; Mancon S; Saitta C; De Carne F; Garofano G; Arena P; Avolio PP; Gobbo A; Uleri A; Contieri R; Paciotti M; Lazzeri M; Hurle R; Casale P; Buffi NM; Lughezzani G
Diagnostics (Basel); 2024 Mar; 14(5):. PubMed ID: 38472997
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.
Kumar NB; Pow-Sang J; Egan KM; Spiess PE; Dickinson S; Salup R; Helal M; McLarty J; Williams CR; Schreiber F; Parnes HL; Sebti S; Kazi A; Kang L; Quinn G; Smith T; Yue B; Diaz K; Chornokur G; Crocker T; Schell MJ
Cancer Prev Res (Phila); 2015 Oct; 8(10):879-87. PubMed ID: 25873370
[TBL] [Abstract][Full Text] [Related]
13. Prostate MRI Was Negative-What's Next?
Seibert TM
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):641-642. PubMed ID: 38689575
[TBL] [Abstract][Full Text] [Related]
14. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Kench JG; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Moch H; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tsuzuki T; Turjalic S; van der Kwast TH; Zhou M; Srigley JR
Histopathology; 2022 Oct; 81(4):447-458. PubMed ID: 35758185
[TBL] [Abstract][Full Text] [Related]
15. A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients.
Brikun I; Nusskern D; Gillen D; Lynn A; Murtagh D; Feczko J; Nelson WG; Freije D
Biomark Res; 2014; 2(1):25. PubMed ID: 25548652
[TBL] [Abstract][Full Text] [Related]
16. Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.
Abdel-Hady A; El-Hindawi A; Hammam O; Khalil H; Diab S; El-Aziz SA; Badawy M; Ismail A; Helmy N; Kamel N; Anis S; Kholy AE; Osili KA; Abdel-Hady A; Nour H; Akl M
Open Access Maced J Med Sci; 2017 Apr; 5(2):147-154. PubMed ID: 28507619
[TBL] [Abstract][Full Text] [Related]
17. Incidental Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia: Analysis from a Contemporary National Dataset.
Bologna E; Licari LC; Franco A; Ditonno F; Manfredi C; De Nunzio C; Antonelli A; De Sio M; Leonardo C; Simone G; Cherullo EE; Autorino R
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611590
[TBL] [Abstract][Full Text] [Related]
18. How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database.
Jambor I; Martini A; Falagario UG; Ettala O; Taimen P; Knaapila J; Syvänen KT; Steiner A; Verho J; Perez IM; Merisaari H; Vainio P; Lamminen T; Saunavaara J; Carrieri G; Boström PJ; Aronen HJ
Acta Radiol Open; 2021 Nov; 10(11):20584601211060707. PubMed ID: 34868663
[TBL] [Abstract][Full Text] [Related]
19. Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort.
Patel HD; Koehne EL; Shea SM; Bhanji Y; Gerena M; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Gupta GN
Cancer; 2022 Jan; 128(1):75-84. PubMed ID: 34427930
[TBL] [Abstract][Full Text] [Related]
20. Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?
Williams C; Ahdoot M; Daneshvar MA; Hague C; Wilbur AR; Gomella PT; Shih J; Khondakar N; Yerram N; Mehralivand S; Gurram S; Siddiqui M; Pinsky P; Parnes H; Merino M; Wood B; Turkbey B; Pinto PA
J Urol; 2022 Jan; 207(1):95-107. PubMed ID: 34433302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
